ici 118551 and transforming growth factor beta

ici 118551 has been researched along with transforming growth factor beta in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, PJ; Haddad, EB; Mak, JC; Rousell, J1
Lu, J; Lu, X; Luo, H; Pu, J; Xu, L; Zhang, X1

Other Studies

2 other study(ies) available for ici 118551 and transforming growth factor beta

ArticleYear
Transforming growth factor-beta1 inhibits beta2-adrenoceptor gene transcription.
    Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 362, Issue:6

    Topics: Adrenergic beta-Antagonists; Binding Sites; Binding, Competitive; Blotting, Northern; Cell Line; Cyclic AMP; Down-Regulation; Embryo, Mammalian; Fibroblasts; Gene Expression; Humans; Imidazoles; Iodine Radioisotopes; Kinetics; Lung; Pindolol; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta-2; RNA, Messenger; Transcription, Genetic; Transforming Growth Factor beta; Transforming Growth Factor beta1

2000
Adrenaline promotes epithelial-to-mesenchymal transition via HuR-TGFβ regulatory axis in pancreatic cancer cells and the implication in cancer prognosis.
    Biochemical and biophysical research communications, 2017, 11-25, Volume: 493, Issue:3

    Topics: Adrenergic beta-Antagonists; Aged; Cell Line, Tumor; Cell Movement; ELAV-Like Protein 1; Epinephrine; Epithelial-Mesenchymal Transition; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Pancreatic Neoplasms; Propanolamines; Receptors, Adrenergic, beta-2; Transforming Growth Factor beta

2017